ZELTIQ Aesthetics (ZLTQ) Shares are Up 3.36%

ZELTIQ Aesthetics (ZLTQ) : Traders are bullish on ZELTIQ Aesthetics (ZLTQ) as it has outperformed the S&P 500 by a wide margin of 16.7% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 2.92%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 3.36% in the last 1 week, and is up 19.6% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

ZELTIQ Aesthetics (NASDAQ:ZLTQ): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $34.71 and $33.87 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $35.12. The buying momentum continued till the end and the stock did not give up its gains. It closed at $35.09, notching a gain of 1.71% for the day. The total traded volume was 804,782 . The stock had closed at $34.50 on the previous day.

The stock has recorded a 20-day Moving Average of 8.29% and the 50-Day Moving Average is 18.01%. ZELTIQ Aesthetics, Inc. is up 21.67% in the last 3-month period. Year-to-Date the stock performance stands at 22.99%.

ZELTIQ Aesthetics (ZLTQ) stock is expected to deviate a maximum of $3.7 from the average target price of $38 for the short term period. 8 Street Experts have initiated coverage on the stock with the most promising target being $43 and the most muted being $32.


ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells, which are needed to perform procedures using its CoolSculpting system. As of December 31, 2014, it had an installed base of 3,176 CoolSculpting systems installed across approximately 2,688 practices across the world. As of December 31, 2014, 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.